Chinese Herbal Medicine Combined With First-Generation EGFR-TKIs in Treatment of Advanced Non-Small Cell Lung Cancer With EGFR Sensitizing Mutation: A Systematic Review and Meta-Analysis

Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. First-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs) significantly improve prognosis of advanced NSCLC patients harboring EGFR sensitizing mutation. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yan, Sun, Chenbing, Jiao, Lijing, Liu, Yu, Gong, Yabin, Xu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429791/
https://www.ncbi.nlm.nih.gov/pubmed/34512332
http://dx.doi.org/10.3389/fphar.2021.698371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429791/
https://www.ncbi.nlm.nih.gov/pubmed/34512332
http://dx.doi.org/10.3389/fphar.2021.698371

Ejemplares similares